By Mill Chart
Last update: Jun 3, 2025
ADMA BIOLOGICS INC (NASDAQ:ADMA) was identified as an affordable growth candidate by our stock screener. The company demonstrates strong growth potential while maintaining reasonable valuation metrics, along with solid financial health and profitability. Below, we break down why ADMA stands out in these key areas.
ADMA has shown impressive growth recently, particularly in earnings and revenue:
These figures indicate a company expanding rapidly in its sector, making it appealing for growth-focused investors.
Despite its strong growth, ADMA remains reasonably valued compared to industry peers:
ADMA’s financial stability adds to its investment case:
While profitability has been inconsistent in the past, recent improvements suggest a positive trend.
Our Affordable Growth screener lists more stocks with similar characteristics and is updated daily.
For a deeper look at ADMA’s fundamentals, review the full report here.
This is not investing advice. The observations here are based on current data, but investors should conduct their own research before making decisions.
20.43
+0.59 (+2.97%)
Find more stocks in the Stock Screener
ADMA Biologics (NASDAQ:ADMA) shows strong growth, reasonable valuation, and solid financial health, making it an attractive candidate for investors seeking affordable growth stocks in the biotech sector.